News brief
On 2026/9/19, AIPressRoom reported that US AI protein design company ImpriMed had raised USD 10 million in Series A funding led by LB Investment.
Connected profiles
Explore
Sources · 1Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
- aipressroom.com ↗Published Sep 19, 2026
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
2026年9月19日，据AIPressRoom报道，美国AI蛋白质设计公司ImpriMed完成1000万美元A轮融资，由LB Investment领投。